Cerevel Therapeutics

Cerevel Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel therapies for devastating neuroscience diseases. Founded in 2018 through a partnership with Pfizer and Bain Capital, Cerevel leverages its deep understanding of brain biology and neurocircuitry, combined with advanced chemistry and central nervous system (CNS) receptor pharmacology, to create innovative treatments. Their pipeline includes multiple preclinical and clinical-stage therapeutic candidates targeting various neurological disorders like Parkinson’s disease, epilepsy, schizophrenia, and Alzheimer’s disease psychosis.

Cerevel is committed to transforming the lives of patients suffering from these debilitating conditions by addressing the unmet medical needs and limited treatment options currently available. They strive to develop therapies that achieve optimal therapeutic activity while minimizing the unintended side effects often associated with existing treatments. Their mission is to push boundaries, develop solutions, and ultimately transform the lives of those living with neuroscience diseases.

Cerevel Therapeutics offers a competitive benefits package to its employees, including comprehensive health and dental insurance. The company also sponsors attendance at professional meetings, conferences, and workshops for its employees.

Cerevel Therapeutics is a clinical-stage biopharmaceutical company dedicated to developing innovative treatments for devastating neuroscience diseases such as Parkinson's disease, epilepsy, and schizophrenia. They combine a deep understanding of brain biology and neurocircuitry with advanced chemistry and CNS receptor pharmacology to discover and develop novel therapies that aim to transform the lives of people affected by these debilitating conditions. Their mission is to push boundaries, develop solutions, and ultimately transform lives by providing new and improved treatment options for patients suffering from underserved areas within neuroscience.

Cerevel Therapeutics fosters a culture built on authenticity, diversity, and a relentless pursuit of results. They value trust, courage, respect, curiosity, and compassion in their employees, creating an environment where individuals are encouraged to be themselves, challenge ideas, learn from one another, and support each other. This collaborative and forward-thinking atmosphere reflects their dedication to achieving meaningful change in the lives of those living with neurological and psychiatric disorders.

Cerevel Therapeutics embraces a mosaic vision of diversity, equity, and inclusion, valuing authenticity and recognizing the importance of diverse perspectives for success. They hire individuals based on their qualifications and contributions, fostering an environment where differences are embraced and treated as valuable assets. Their core values of trust, courage, respect, curiosity, and compassion guide their approach to building a team that reflects the diversity of their patient communities.